--- title: HR 1794. Commissioner of Insurance; conduct a comprehensive review of prescription drug pricing and identify strategies to reduce the cost of prescription medications; urge collection: bills id: 2025-2026/hr1794 cite_as: HR 1794, 2025-2026 Regular Session (Ga.) canonical_url: https://georgiacommons.org/bills/2025-2026/hr1794 md_url: https://georgiacommons.org/bills/2025-2026/hr1794.md text_url: https://georgiacommons.org/bills/2025-2026/hr1794/text source_url: https://www.legis.ga.gov/legislation/74273 date: 2026-03-23 status: introduced corpus_version: bills-2026-09-13 license: Public record of the Georgia General Assembly, via LegiScan; see about.md publisher: Georgia Commons, an independent project of Georgia Civic Data. Not the State of Georgia. Not legal advice. up: https://georgiacommons.org/bills/2025-2026.md previous: https://georgiacommons.org/bills/2025-2026/hr1793.md next: https://georgiacommons.org/bills/2025-2026/hr1795.md index: https://georgiacommons.org/bills/index.md omitted: votes and history omitted_chars: 129 omitted_url: https://georgiacommons.org/bills/2025-2026/hr1794.md?full=1 bill_number: HR 1794 session: 2025-2026 Regular Session session_slug: 2025-2026 chamber: House bill_type: resolution status_date: 2026-03-19 last_action: House Second Readers sponsors: - Bryce Berry - Tangie Herring - Samuel Park - Spencer Frye - Carolyn Hugley - Eric Gisler text_version: Introduced has_text: true legiscan_url: https://legiscan.com/GA/bill/HR1794/2025 upstream_id: 2136397 summaries_model: claude-sonnet-5 topic_tags: - prescription drug prices - health insurance - pharmacy benefit managers - consumer protection --- # HR 1794. Commissioner of Insurance; conduct a comprehensive review of prescription drug pricing and identify strategies to reduce the cost of prescription medications; urge ## Text House Resolution 1794 By: Representatives Berry of the 56th, Herring of the 145th, Park of the 107th, Frye of the 122nd, Hugley of the 141st, and others A RESOLUTION Urging the Commissioner of Insurance to conduct a comprehensive review of prescription drug pricing and identify strategies to reduce the cost of prescription medications for citizens of the State of Georgia; and for other purposes. WHEREAS, the cost of prescription drugs has increased significantly in recent years, placing a substantial financial burden on patients, families, employers, and public health programs across the State of Georgia; and WHEREAS, high prescription drug prices can lead to decreased medication adherence, resulting in worsened health outcomes and increased long-term healthcare costs; and WHEREAS, greater transparency of pharmaceutical pricing, including the roles of manufacturers, pharmacy benefits managers, insurers, and other stakeholders, is necessary to fully understand cost drivers within the pharmaceutical supply chain; and WHEREAS, other states have undertaken comprehensive reviews of prescription drug affordability, including the use of all-payer claims data, advisory panels, and reporting requirements to better understand pricing trends and identify policy solutions; and WHEREAS, a coordinated, evidence based review in Georgia would help identify opportunities to improve affordability, enhance transparency, and ensure that cost savings are passed on to consumers; and WHEREAS, the Office of the Commissioner of Insurance is uniquely positioned to evaluate insurance market practices, claims data, and pricing structures affecting prescription drug costs in Georgia. NOW, THEREFORE, BE IT RESOLVED BY THE HOUSE OF REPRESENTATIVES that the members of this body urge the Commissioner of Insurance to conduct a comprehensive review of prescription drug pricing and identify strategies to reduce the cost of prescription medications for citizens of the State of Georgia. BE IT FURTHER RESOLVED that a report of findings and recommendations be submitted to the Governor, the President of the Senate, and the Speaker of the House of Representatives. BE IT FURTHER RESOLVED that the Clerk of the House of Representatives is authorized and directed to make appropriate copies of this resolution available for distribution to the Commissioner of Insurance, the public, and the press. ## Summaries written by Georgia Commons The following was written by claude-sonnet-5 from the text above and is not part of the resolution. Quote the text, not the summary. A Georgia House resolution would urge the state Commissioner of Insurance to study prescription drug pricing and recommend ways to lower medication costs for Georgians. ### Plain-language summary This resolution does not change Georgia law. Instead, it expresses the House's wish that the Commissioner of Insurance, who oversees Georgia's insurance market, conduct a comprehensive review of prescription drug pricing. The review would look at cost drivers throughout the pharmaceutical supply chain, including drug manufacturers, pharmacy benefit managers, and insurers, and would aim to identify strategies to reduce prescription drug costs for people in Georgia. The resolution notes that other states have used tools like all-payer claims data, advisory panels, and reporting requirements to study drug affordability, and suggests Georgia could take a similar approach. It calls for a report of findings and recommendations to be sent to the Governor, the President of the Senate, and the Speaker of the House, and directs the Clerk of the House to distribute copies to the Commissioner of Insurance, the public, and the press. ### What it does - Urges (but does not legally require) the Commissioner of Insurance to conduct a comprehensive review of prescription drug pricing in Georgia. - Asks the review to identify strategies for reducing prescription medication costs for Georgia residents. - Calls for a report on findings and recommendations to be submitted to the Governor, the Senate President, and the House Speaker. - Directs the Clerk of the House to distribute copies of the resolution to the Commissioner of Insurance, the public, and the press. ### Who it affects The Commissioner of Insurance's office, which would be asked to lead the review; Georgia patients and families facing prescription drug costs; and stakeholders in the pharmaceutical supply chain such as drug manufacturers, pharmacy benefit managers, and insurers whose practices would be examined. ### Why it matters If the Commissioner acts on this request, Georgians could eventually see a public report explaining what drives high prescription drug costs and possible policy fixes. Because it is a resolution rather than a law, nothing is legally mandated and no new rules or funding are created. ### Key provisions - The resolution recites findings that rising drug prices burden patients, families, employers, and public health programs in Georgia. - It notes that other states have used all-payer claims data, advisory panels, and reporting requirements to study drug affordability. - The operative resolving clause urges the Commissioner of Insurance to conduct a comprehensive pricing review and identify cost-reduction strategies. - A further resolving clause requires a report of findings and recommendations to go to the Governor, the Senate President, and the House Speaker. - A final clause directs the Clerk of the House to distribute copies to the Commissioner of Insurance, the public, and the press. ## Status - Status: Introduced (2026-03-19) - Last action: House Second Readers (2026-03-23) - Sponsors: Bryce Berry, Tangie Herring, Samuel Park, Spencer Frye, Carolyn Hugley, Eric Gisler - Official page: https://www.legis.ga.gov/legislation/74273 > The history, votes, and amendments (129 characters) are at https://georgiacommons.org/bills/2025-2026/hr1794.md?full=1